Bilibili (NASDAQ:BILI) Stock Rating Lowered by UBS Group

UBS Group lowered shares of Bilibili (NASDAQ:BILI – Free Report) from a buy rating to a neutral rating in a research report released on Monday, Marketbeat Ratings reports. UBS Group currently has $13.20 price target on the stock, down from their prior price target of $22.00. BILI has been the subject of a number of […]

Leave a Reply

Your email address will not be published.

Previous post Inovio Pharmaceuticals (NASDAQ:INO) Now Covered by Analysts at StockNews.com
Next post Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated by Analysts at StockNews.com